$55.59
$-1.59 (-2.86%)
End-of-day quote: 05/13/2024
NasdaqCM:EXAS
Exact Sciences Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | SWX | Hold | CHF93.49 | CHF105.00 | 0.00% | 9 | CHF190.76B |
| ROG | Roche Holding | SWX | Hold | CHF224.60 | CHF307.83 | 0.00% | 9 | CHF181.26B |
| A | Agilent Technologies | NYSE | Outperform | $151.28 | $138.82 | 0.00% | 10 | $44.33B |
| ILMN | Illumina | NasdaqGS | Outperform | $115.58 | $159.28 | 0.00% | 9 | $18.41B |
| LH | Laboratory Corp of America Hol... | NYSE | Outperform | $211.20 | $241.28 | 0.00% | 9 | $17.80B |
| HOLX | Hologic | NasdaqGS | Outperform | $75.65 | $81.06 | 0.00% | 3 | $17.65B |
| DGX | Quest Diagnostics | NYSE | Outperform | $139.16 | $141.17 | 0.00% | 8 | $15.38B |
| ERF | Eurofins Scientific | ENXTPA | Hold | 58.20€ | 0.00€ | 0.00% | 5 | 11.05€B |
| NTRA | Natera | NasdaqGS | Buy | $105.52 | $74.41 | 0.00% | 8 | $11.68B |
| QGEN | QIAGEN N.V. | NYSE | Outperform | $45.39 | $0.00 | 0.00% | 3 | $9.67B |
| SHL | Sonic Healthcare | ASX | Hold | $27.62 | $34.12 | 0.00% | 0 | $12.78B |
| BIO | Bio-Rad Laboratories Inc | NYSE | Outperform | $294.01 | $536.80 | 0.00% | 1 | $7.92B |
| TXG | 10x Genomics | NasdaqGS | Outperform | $26.56 | $58.14 | 0.00% | 2 | $3.16B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $48.13 | $34.00 | 0.00% | 2 | $2.40B |
| GH | Guardant Health | NasdaqGS | Buy | $24.73 | $43.00 | 0.00% | 2 | $2.37B |
| NEO | NeoGenomics | NasdaqCM | Outperform | $15.40 | $20.09 | 0.00% | 9 | $1.95B |
| SDGR | Schrödinger | NasdaqGS | Outperform | $23.25 | $44.22 | 0.00% | 1 | $1.84B |
| MYGN | Myriad Genetics | NasdaqGS | Outperform | $25.36 | $22.08 | 0.00% | 8 | $1.79B |
| VCYT | Veracyte | NasdaqGM | Outperform | $23.02 | $32.17 | 0.00% | 4 | $1.61B |
| OPK | OPKO Health | NasdaqGS | Outperform | $1.01 | $6.70 | 0.00% | 0 | $1.18B |
| LAB | Standard BioTools | NasdaqGS | Buy | $2.54 | $4.00 | 0.00% | 1 | $856.71M |
| CYRX | Cryoport | NasdaqCM | Outperform | $13.44 | $17.61 | 0.00% | 3 | $806.30M |
| FLGT | Fulgent Genetics | NasdaqGM | Hold | $22.32 | $31.50 | 0.00% | 2 | $642.86M |
| CDNA | CareDx, Inc | NasdaqGM | Outperform | $15.24 | $11.80 | 0.00% | 1 | $575.21M |
| ADPT | Adaptive Biotechnologies | NasdaqGS | Outperform | $3.96 | $8.67 | 0.00% | 2 | $515.79M |
| VNET | VNET Group | NasdaqGS | Outperform | $1.95 | $33.17 | 0.00% | 0 | $444.73M |
| CRDF | Cardiff Oncology | NasdaqCM | Buy | $3.58 | $8.37 | 0.00% | 1 | $154.70M |
| PSNL | Personalis | NasdaqGM | Outperform | $1.52 | $4.45 | 0.00% | 3 | $80.14M |
| AGL | ANGLE | AIM | Buy | £0.21 | £0.97 | 0.00% | 0 | £46.23M |
| MAP | Microba Life Sciences | ASX | Buy | $0.18 | $0.44 | 0.00% | 1 | $76.13M |
| OCX | OncoCyte | NasdaqCM | Outperform | $2.90 | $3.90 | 0.00% | 0 | $38.62M |
| CNTG | Centogene N.V. | NasdaqGM | Outperform | $0.42 | $1.37 | 0.00% | 0 | $23.96M |
| DMTK | DermTech | NasdaqCM | Outperform | $0.64 | $3.60 | 0.00% | 4 | $21.63M |
| TCRT | Alaunos Therapeutics | NasdaqCM | Hold | $1.29 | $1.37 | 0.00% | 3 | $20.58M |
| FRES | Fresh2 Group | NasdaqCM | - | $0.39 | $0.00 | 0.00% | 0 | $20.50M |
| AXDX | Accelerate Diagnostics | NasdaqCM | Buy | $0.91 | $5.00 | 0.00% | 1 | $19.07M |
| NSTG | NanoString Technologies | NasdaqGM | - | $0.12 | $5.02 | 0.00% | 4 | $5.17M |
| NVTA | Invitae | NYSE | - | $0.00 | $0.71 | 0.00% | 8 | $3.18M |
| ECX | Epigenomics | XTRA | Outperform | 1.64€ | 52.65€ | 0.00% | 1 | 1.44€M |
| MOTS | Motus GI Holdings | NasdaqCM | - | $0.09 | $8.30 | 0.00% | 2 | $0.37M |
| BIOC.Q | Biocept | OTCPK | Hold | $0.00 | $8.00 | 0.00% | 0 | $0.13M |
| MTST | MetaStat | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
| HTGM.Q | HTG Molecular Diagnostics | OTCPK | - | $0.00 | $6.00 | 0.00% | 1 | $0.00M |
